Similarly, TILs from cholangiocarcinoma patients containing Th1 CD4+ subsets recognize a cancer-expressed mutated erbb2-interacting protein (ERBB2IP), as shown by the whole-exome-sequencing-based approach. The gene discussed is CD4; the disease is cancer.